Please login to the form below
C4X Discovery
This page shows the latest C4X Discovery news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca and C4X Discovery sign exclusive $403m licensing deal
AstraZeneca (AZ) and C4X Discovery (C4XD) have signed an exclusive worldwide licensing agreement worth up to $403m to develop an oral therapy for the treatment of inflammatory and respiratory diseases using ... The drug discovery company is also eligible
Latest news
-
Horizon Discovery and C4X to harness CRISPR for new cancer drugs
UK companies combine computational and genomic platforms. Gene-editing specialists Horizon Discovery is to work with C4X Discovery to exploit CRISPR-Cas9 and other novel technologies to develop new oncology candidates. ... C4X Discovery (C4XD), a
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest appointments
-
C4X Discovery appoints chief executive officer
He joined C4X Discovery in 2014 as non-executive chairman, bringing over 30 years of experience in the pharmaceutical and biotechnology industries to the firm. ... In addition to his new role at C4X Discovery, Dix also serves as chairman of Calchan
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
